Pseudomonas Aeruginosa Infection (DBCOND0051962)
Identifiers
- Synonyms
- Infection Pseudomonas aeruginosa / Pseudomonas aeruginosa Infection / Sepsis due to Pseudomonas / Pseudomonas aeruginosa infection NOS / Pseudomonas Infections / Pseudomonas infection / Pseudomonas infection NOS / Bacterial infection due to Pseudomonas (disorder) / Pseudomonal infections
Associated Data
- Indicated Drugs and Targets
Drug Description Targets Aztreonam A beta-lactam antibiotic used to treat select aztreonam sensitive gram negative bacteria.- Penicillin-binding protein 3target
- Beta-lactamasetarget
- Beta-lactamase Toho-1target
- Peptidoglycan synthase FtsItarget
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT04636554 Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia No drug interventions Not Available Not Available no_longer_available NCT06417593 Phenotypic and Genotypic Characteristics of Pseudomonas Aeruginosa Isolates in Sohag University Hospitals No drug interventions Not Available Not Available recruiting NCT06319235 Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG® treatment 1 / 2 recruiting NCT01563263 Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43 treatment 2 / 3 completed NCT06093191 Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis treatment 4 recruiting NCT04803708 Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers No drug interventions treatment 1 / 2 completed NCT01315678 Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections treatment 3 completed NCT01429259 Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children treatment 4 completed NCT06548841 Development and Validation of (Bio)Sensors for the Identification of Pathogens No drug interventions Not Available Not Available recruiting NCT02421120 Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients other 4 completed NCT01577368 Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas Aeruginosa treatment 3 completed